All resources
Research

Utilizing wearable device data for syndromic surveillance: A fever detection approach

Utilizing wearable device data for syndromic surveillance: A fever detection approach

Description

This peer-reviewed validation study published in Sensors evaluated the feasibility of using physiological data from consumer wearables for large-scale public health screening. Analyzing a massive dataset from 16,794 participants, researchers evaluated nocturnal metrics to isolate 724 self-reported fever events against 342,430 non-fever baseline days.

Using a tree-based machine learning classifier trained on nocturnal skin temperature trends, heart rate, and sleep patterns, the model successfully identified acute fever onset. The algorithm achieved an AUROC of 0.85 and demonstrated a low false positive rate of 0.8% at 0.50 sensitivity, showcasing how objective insights from Oura Ring support live health screening.

Expert perspective

“Implementing these models could increase our ability to detect disease prevalence and spread in real-time during infectious disease outbreaks.”


Notes

*Currently not available through the John Hancock Vitality Program in Guam, Puerto Rico, New Mexico, North Dakota, New York, and Vermont.

Vitality is the provider of the John Hancock Vitality Program in connection with policies issued by John Hancock. John Hancock Vitality Program rewards and discounts are available only to the person insured under the eligible life insurance policy, may vary based on the type of insurance policy purchased and the state where the policy was issued, are subject to change and are not guaranteed to remain the same for the life of the policy. John Hancock insurance products are issued by: John Hancock Life Insurance Company (U.S.A.), Boston, MA 02116 (not licensed in New York) and John Hancock Life Insurance Company of New York, Valhalla, NY 10595. MLINY051023599-1


Could your organization benefit from Oura?

Let’s discuss your needs and discover how Oura can help you.

Contact us